CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21,334 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01622140
NCT01622140N/ACompleted

Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis

Centers for Disease Control and Prevention·observational·Posted Jun 18, 2012·Updated Jan 28, 2021

In Brief

An observational study for Latent Tuberculosis Infection and Tuberculosis. Completed, enrolled 21,334 participants across 10 sites.

Detailed Summary

This is a prospective cohort study of persons tested for latent tuberculosis infection at either high risk for exposure to Mycobacterium tuberculosis or high risk for progression to tuberculosis disease. The study will assess the relative performance and cost of three diagnostic tests for latent tuberculosis infection (tuberculin skin test, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB) and will examine the rates of positive results among the cohort. This study will also determine the risk and rate of progression to active TB disease, overall and by the results of the three tests.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 18, 2012
Enrollment StartOct 1, 2012
Primary CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 14.0 years ago